The Melbourne ME/CFS Collaboration  seeks to characterize the unifying biological pathways of ME/CFS that relate to the shared disease experience between patients while also understanding each patient’s unique biology that creates variation in disease experience and severity.

Chris Armstrong, PhD, was OMF’s Science Liaison and a Visiting Scholar at Stanford. He completed his PhD in Biochemistry at the University of Melbourne, and has been involved with researching ME/CFS for over a decade. 

Dr. Armstrong is most well known for his research using metabolomics to observe biochemical alterations in ME/CFS patients. He began his work in this field at the University of Melbourne, beginning a PhD project to apply metabolomics to study  (ME/CFS) and published his first metabolomics study on blood and urine in 2015.

Since then Chris has set up collaborative efforts to apply metabolomics to immunological experiments on ME/CFS, observing how metabolism may relate to immune cell function. He has also focused on longitudinal research in ME/CFS while looking to extend metabolic capabilities across the field of ME/CFS to help collate different patient group